Browsing by Subject "Molybdenum"

Now showing 1 - 2 of 2
  • Thumbnail Image
    ItemOpen Access
    Outcomes of metallic stents for malignant ureteral obstruction.
    (J Urol, 2012-09) Goldsmith, Zachariah G; Wang, Agnes J; Bañez, Lionel L; Lipkin, Michael E; Ferrandino, Michael N; Preminger, Glenn M; Inman, Brant A
    PURPOSE: Malignant ureteral obstruction often necessitates chronic urinary diversion and is associated with high rates of failure with traditional ureteral stents. We evaluated the outcomes of a metallic stent placed for malignant ureteral obstruction and determined the impact of risk factors previously associated with increased failure rates of traditional stents. MATERIALS AND METHODS: Patients undergoing placement of the metallic Resonance® stent for malignant ureteral obstruction at an academic referral center were identified retrospectively. Stent failure was defined as unplanned stent exchange or nephrostomy tube placement for signs or symptoms of recurrent ureteral obstruction (recurrent hydroureteronephrosis or increasing creatinine). Predictors of time to stent failure were assessed using Cox regression. RESULTS: A total of 37 stents were placed in 25 patients with malignant ureteral obstruction. Of these stents 12 (35%) were identified to fail. Progressive hydroureteronephrosis and increasing creatinine were the most common signs of stent failure. Three failed stents had migrated distally and no stents required removal for recurrent infection. Patients with evidence of prostate cancer invading the bladder at stent placement were found to have a significantly increased risk of failure (HR 6.50, 95% CI 1.45-29.20, p = 0.015). Notably symptomatic subcapsular hematomas were identified in 3 patients after metallic stent placement. CONCLUSIONS: Failure rates with a metallic stent are similar to those historically observed with traditional polyurethane based stents in malignant ureteral obstruction. The invasion of prostate cancer in the bladder significantly increases the risk of failure. Patients should be counseled and observed for subcapsular hematoma formation with this device.
  • Thumbnail Image
    ItemOpen Access
    Structure-Function Studies in Sulfite Oxidase with Altered Active Sites
    (2009) Qiu, James

    Sulfite oxidase, a metabolically important enzyme, catalyzes the physiologically critical conversion of sulfite to sulfate in the terminal step of the degradation of sulfur containing compounds. The enzyme has been the focus for much research since its discovery in the 1950's. A central question to understanding the mechanism of molybdoenzymes such as sulfite oxidase and nitrate reductase concerns the roles of active site residues and the coordination chemistry of the Mo atom in the structure and function of the enzyme. The goal of this work was directed towards the characterization and determination of the structures of active site variants of sulfite oxidase using a spectroscopic, kinetic, and protein crystallographic approach.

    Earlier studies have identified a single, highly conserved cysteine residue as the donor of a covalent bond from the protein to molybdenum in sulfite oxidase and nitrate reductase. The C185S and C185A variants of chicken sulfite oxidase exhibited severely attenuated activity. Crystallographic and spectroscopic analysis of both variants revealed a change in the metal coordination, from a dioxo to a trioxo form of Mo.

    Assimilatory nitrate reductase is a member of the sulfite oxidase family of molybdopterin enzymes. The crystal structure of the Mo domain of the enzyme from Pichia angusta revealed high structural homology in the active sites of nitrate reductase and sulfite oxidase. Both enzymes utilize the same form of the molybdenum cofactor and have three out of five residues conserved at the active site. Substitution of two active site residues in sulfite oxidase alters the substrate affinity of chicken SO from sulfite to nitrate, resulting in an increase of nitrate reductase activity over wild-type sulfite oxidase. Additionally we identified an additional amino acid position in sulfite oxidase that corresponds to a non-conserved position in NR that further increased NR activity. Finally, these nitrate reductase variants of sulfite oxidase were crystallized and the structures solved. This represents the first example of the transmutation of a molybdenum enzyme to change activity and substrate affinity to those of a homologous enzyme.